This program was possible with support from Bayer.
Expert perspectives on how clinical trials and real-world evidence contribute to treatment decisions in prostate cancer.
Dana-Farber | Strategic Alliance Partners
Latest from Dana-Farber
This program was possible with support from Bayer.
A genitourinary oncologist provides insights on the treatment decision-making process and the roles of guidelines for prostate cancer.
This program was possible with support from Bayer.
Clinical insights on the typical presentation of prostate cancer and how the disease is diagnosed.
This program was possible with support from Bayer.
Alicia Morgans, MD, MPH, reviews the incidence of prostate cancer and risk factors associated with the disease.
Advertisement
Advertisement
Trending on CURE
1
Why a Patient With Pancreatic Cancer Moved From Chemotherapy to Rasonque
2
5 Lung Cancer Immunotherapy Side Effects and How to Manage Them
3
Rasonque for Pancreatic Cancer: Patients Discuss Benefits, Risks and Access
4
Sac-TMT Plus Keytruda Improves Outcomes in PD-L1-Negative Lung Cancer
5